The Latest Cardiac and Vascular News
EDEN PRAIRIE, Minn., March 03, 2020 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the fourth quarter and year ended December 31, 2019, which included the following highlights: Received 510(k) clearance in the U.S. and […]
EDEN PRAIRIE, Minn., Feb. 26, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) today announced FDA 510(k) clearance in the U.S. of its next generation Aquadex SmartFlow console for use in adult and pediatric patients who weigh 20kg or more. The console is a simple, gentle, […]
EDEN PRAIRIE, Minn., Feb. 12, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) today announced the initiation of distribution agreements covering Germany, Austria and Switzerland with Neucomed Group and its affiliates, further expanding its commercial presence in the European Union. […]
EDEN PRAIRIE, Minn., Jan. 22, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) today announced that Texas-based health system, Baylor Scott & White Health has initiated offering aquapheresis therapy using the company’s Aquadex FlexFlow® system at its Baylor Scott & White […]
EDEN PRAIRIE, Minn., Jan. 08, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) today announced results from an investigator-initiated retrospective analysis of utilization of the Aquadex FlexFlow aquapheresis system at Lenox Hill Hospital in New York City. The study was […]
EDEN PRAIRIE, Minn., Dec. 03, 2019 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) today announced that Memphis, Tennessee-based health system, Methodist Le Bonheur, has initiated offering aquapheresis therapy to patients suffering from fluid overload using the company’s Aquadex FlexFlow system. […]
EDEN PRAIRIE, Minn., Nov. 05, 2019 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (Nasdaq: CHFS), a medical device company focused on developing, manufacturing and commercializing a clinically proven solution for diuretic-resistant patients suffering from fluid overload, announced today its results for […]
First Study of Aquadex FlexFlow System Sponsored by United States Veterans Administration for Aquapheresis Treatment in Patients Suffering from Fluid Overload. First patient enrollment expected in the fourth quarter of 2019. EDEN PRAIRIE, Minn., Oct. 10, 2019 (GLOBE NEWSWIRE) — […]
EDEN PRAIRIE, Minn., Sept. 04, 2019 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (Nasdaq:CHFS) today announced that Maria Rosa Costanzo, M.D. has been appointed to the Company’s Board of Directors. Dr. Costanzo is the medical director, Heart Failure Research, at Advocate […]
EDEN PRAIRIE, Minn., June 13, 2019 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), today announced highlights from the sponsored session from the American Association for Thoracic SurgeryAnnual Meeting moderated by Daniel Beckles, M.D., Ph.D. of United Health Services Hospitals in Binghamton, N.Y. The full session can be found […]
